Kim HD - Search Results

1

Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.

Kim HD, Im HS, Kim JH, Jeong H, Yoon SK, Park I, Lee JL. Kim HD, et al. Among authors: kim jh. Cancer Res Treat. 2021 Oct;53(4):1166-1173. doi: 10.4143/crt.2021.091. Epub 2021 Mar 4. Cancer Res Treat. 2021. PMID: 33677847 Free PMC article.

2

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.

Kim HD, Kim JH, Ryu YM, Kim D, Lee S, Shin J, Hong SM, Kim KH, Jung DH, Song GW, Hwang DW, Lee JH, Song KB, Ryoo BY, Jeong JH, Kim KP, Kim SY, Yoo C. Kim HD, et al. Among authors: kim d, kim kp, kim sy, kim kh, kim jh. Cancer Res Treat. 2021 Jan;53(1):162-171. doi: 10.4143/crt.2020.704. Epub 2020 Aug 31. Cancer Res Treat. 2021. PMID: 32878426 Free PMC article.

3

A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels.

Kim HD, Cho H, Jeong H, Bang K, Kim S, Lee K, Kang EH, Park JS, Park CS, Huh J, Ryu JS, Lee SW, Yoon DH, Oh SY, Suh C. Kim HD, et al. Among authors: kim s. Br J Haematol. 2021 Apr;193(2):307-315. doi: 10.1111/bjh.17222. Epub 2020 Nov 20. Br J Haematol. 2021. PMID: 33216979 Free article. Clinical Trial.

4

Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.

Kim HD, Cho H, Kim S, Lee K, Kang EH, Park JS, Park CS, Huh J, Ryu JS, Lee SW, Yoon DH, Kim SJ, Ko YH, Kim WS, Suh C. Kim HD, et al. Among authors: kim s, kim sj, kim ws. Cancer Res Treat. 2021 Jul;53(3):847-856. doi: 10.4143/crt.2020.1060. Epub 2020 Dec 17. Cancer Res Treat. 2021. PMID: 33332932 Free PMC article.

5

Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.

Bang Y, Yoo C, Lonardi S, Kim HD, Vivaldi C, Rimini M, Frassineti GL, Park SR, Rizzato MD, Ryu MH, Salani F, Rapposelli IG, Ryoo BY, Zagonel V, Massa V, Valgiusti M, Burgio V, Scartozzi M, Cascinu S, Casadei-Gardini A. Bang Y, et al. Among authors: kim hd. Target Oncol. 2021 May;16(3):401-410. doi: 10.1007/s11523-021-00797-3. Epub 2021 Mar 1. Target Oncol. 2021. PMID: 33646487

6

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.

Jeong H, Park KJ, Lee Y, Kim HD, Kim JH, Yoon S, Hong B, Lee JL. Jeong H, et al. Among authors: kim hd, kim jh. Cancer Res Treat. 2022 Jan;54(1):226-233. doi: 10.4143/crt.2021.365. Epub 2021 May 6. Cancer Res Treat. 2022. PMID: 33957019 Free PMC article.

7

Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab.

Cho H, Ryu MH, Lee HE, Kim HD, Kang YK. Cho H, et al. Among authors: kim hd. Cancer Immunol Immunother. 2022 Apr;71(4):829-838. doi: 10.1007/s00262-021-03035-x. Epub 2021 Aug 22. Cancer Immunol Immunother. 2022. PMID: 34420059 Free PMC article.

8

Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study.

Kim HD, Lee JS, Yook JH, Ryu MH, Park YK, Kim JY, Kim YW, Oh SC, Kim JG, Cheong JH, Jeong O, Noh SH, Kang YK. Kim HD, et al. Among authors: kim jy, kim jg, kim yw. Gastric Cancer. 2022 Jan;25(1):170-179. doi: 10.1007/s10120-021-01243-z. Epub 2021 Sep 2. Gastric Cancer. 2022. PMID: 34476643

9

Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified.

Kim HD, Cho H, Sohn BS, Park CS, Huh J, Ryu JS, Lee SW, Yoon SE, Kim SJ, Ko YH, Kim WS, Suh C. Kim HD, et al. Among authors: kim sj, kim ws. Leuk Lymphoma. 2022 Jan;63(1):124-130. doi: 10.1080/10428194.2021.1971220. Epub 2021 Oct 26. Leuk Lymphoma. 2022. PMID: 34702115

10

Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis.

Kang S, Ryu MH, Bang YH, Kim HD, Lee HE, Kang YK. Kang S, et al. Among authors: kim hd. Cancer Res Treat. 2022 Oct;54(4):1167-1174. doi: 10.4143/crt.2021.1040. Epub 2021 Dec 6. Cancer Res Treat. 2022. PMID: 34883555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,250 results

Search Page

Filters